ABION Inc. is a Korea-based company principally engaged in the research, development and sales of pharmaceuticals. Along with its subsidiaries, the Company operates its business through four segments including product segment, contract research organization (CRO) service segment, research segment and other segment. The Product segment produces and sells diagnostic reagents, research reagents, and stem cell culture medium. The CRO Service segment provides histopathology analysis, molecular genetic analysis, cellular immunoassay, and antibody detection services. The Research segment is engaged in research and development of drugs for protein therapeutics, nucleic acid therapeutics, and antibody therapeutics.

Employees

Sector

Biotechnology & Medical Research

Calendar

08/10 Significant Split/Dividend

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 14/08/2026			5-day change	1st Jan Change
676.00 ^KRW	-2.03%		-.--%	-78.40%

07/04	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs	CI
04/25/04	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc	RE

Market Cap	6.09TCr 4.49Cr 3.86Cr 3.62Cr 3.31Cr 6.19Cr 424.12Cr 6.24Cr 43Cr 17Cr 216.74Cr 17Cr 16Cr 698.04Cr	P/E 2024	-4.02x	P/E 2025	-7.21x
Enterprise Value	3.26TCr 2.4Cr 2.06Cr 1.94Cr 1.77Cr 3.31Cr 226.82Cr 3.33Cr 23Cr 8.93Cr 115.92Cr 9.01Cr 8.81Cr 373.32Cr	EV / Sales 2024	282x	EV / Sales 2025	288x
Free-Float	73.67%	Yield 2024 *	-	Yield 2025	-

07/04	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs	CI
04/25/04	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc	RE
30/24/30	Nuon Co., Ltd. completed the acquisition of 4.06% stake in ABION Inc. from KPM TECH Co., Ltd..	CI
26/24/26	KPM TECH Co., Ltd. announced that it has received KRW 5.999999711 billion in funding from ABION Inc.	CI
23/24/23	Nuon Co., Ltd. agreed to acquire 4.06% stake in ABION Inc. from KPM TECH Co., Ltd. for KRW 8 billion.	CI
23/24/23	ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
18/24/18	KPM TECH Co., Ltd. announced that it expects to receive KRW 5.999999711 billion in funding from ABION Inc.	CI
05/24/05	ABION Inc. completed the acquisition of 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc..	CI
05/24/05	ABION Inc. announced that it has received KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
11/24/11	ABION Inc. announced that it expects to receive KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
11/24/11	ABION Inc. agreed to acquire 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc. for KRW 20.1 billion.	CI
28/24/28	ABION Inc. announced that it expects to receive KRW 9.999995616 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	CI
28/23/28	Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.	CI

1 day	-2.03%
1 month	+1.96%
3 months	-62.94%
6 months	-78.57%
Current year	-78.40%

Abion Inc. Share Price

Stocks

A203400

KR7203400007

Biotechnology & Medical Research

Valuation : Abion Inc.

Chart: Abion Inc.

Latest news : Abion Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Abion Inc.

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

1 month	587	1,093
Current year	570	4,335
1 year	570	4,510
3 years	570	7,277.78
5 years	570	14,694.44
10 years	570	14,694.44

Manager	Title	Age	Since
Young-Gi Shin CEO	Chief Executive Officer	55	01/08/2010
Seong-Yun Woo DFI	Director of Finance/CFO	45	28/03/2025
Gi-Ryong Jang COO	Chief Operating Officer	46	01/01/2026

Director	Title	Age	Since
Young-Gi Shin BRD	Director/Board Member	55	31/12/2014
Jin-Wook Yang BRD	Director/Board Member	56	25/03/2022
Geun-Chul Park BRD	Director/Board Member	70	-

Date	Insider	Type	Quantity	% Market Cap.	Importance
08/12/25	Sun-mi Chang	Free	27	0.0001%	-
08/12/25	Yang-mi Lim	Buy	115	0.0002%
08/12/25	Yang-mi Lim	Free	92	0.0002%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABION INC.	-2.03%	-.--%	-77.88%	-85.12%	4.48Cr
WUXI APPTEC CO., LTD.	+1.03%	-2.05%	+39.28%	+94.60%	6.89TCr
ARGENX SE	+1.31%	+0.55%	+49.48%	+92.12%	6.53TCr
INSMED INCORPORATED	-0.93%	+3.20%	-12.70%	+375.09%	2.77TCr
WUXI BIOLOGICS (CAYMAN) INC.	+2.97%	-0.10%	+41.86%	+14.84%	2.58TCr
BIONTECH SE	-0.95%	-7.76%	+2.32%	-15.78%	2.61TCr
GENMAB A/S	+1.01%	+1.38%	+26.48%	-17.50%	2.01TCr
PHARMAESSENTIA CORPORATION	+3.45%	-14.83%	+225.22%	+389.50%	1.7TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.77%	-4.55%	-0.36%	+549.41%	1.5TCr
EXELIXIS, INC.	+1.39%	+7.66%	+60.97%	+167.15%	1.45TCr
Average	+0.81%	-4.35%	+35.47%	+156.43%	2.8TCr
Weighted average by Cap.	+1.05%	-2.12%	+42.68%	+142.04%

	2024	2025
Net sales	76Cr 6L 5L 5L 4L 8L 5.29Cr 8L 53.45L 20.82L 2.7Cr 21.01L 20.56L 8.71Cr	88Cr 6L 6L 5L 5L 9L 6.13Cr 9L 61.92L 24.12L 3.13Cr 24.35L 23.81L 10Cr
Net income	-4.34TCr -3.2Cr -2.75Cr -2.58Cr -2.36Cr -4.41Cr -302.07Cr -4.44Cr -31Cr -12Cr -154.37Cr -12Cr -12Cr -497.18Cr	-2.91TCr -2.14Cr -1.84Cr -1.73Cr -1.58Cr -2.95Cr -202.38Cr -2.98Cr -20Cr -7.96Cr -103.42Cr -8.04Cr -7.86Cr -333.08Cr
Net Debt	1.4TCr 1.03Cr 89.02L 83.54L 76.43L 1.43Cr 98Cr 1.44Cr 9.88Cr 3.85Cr 50Cr 3.89Cr 3.8Cr 160.98Cr	-2.83TCr -2.09Cr -1.8Cr -1.69Cr -1.54Cr -2.88Cr -197.29Cr -2.9Cr -20Cr -7.76Cr -100.83Cr -7.84Cr -7.67Cr -324.72Cr